Cite
Targeting Integrin α4β7 in Steroid-Refractory Intestinal Graft-versus-Host Disease.
MLA
Fløisand, Yngvar, et al. “Targeting Integrin Α4β7 in Steroid-Refractory Intestinal Graft-versus-Host Disease.” Biology of Blood & Marrow Transplantation, vol. 23, no. 1, Jan. 2017, pp. 172–75. EBSCOhost, https://doi.org/10.1016/j.bbmt.2016.10.009.
APA
Fløisand, Y., Lundin, K. E. A., Lazarevic, V., Kristiansen, J. D., Osnes, L. T. N., Tjønnfjord, G. E., Reims, H. M., & Gedde-Dahl, T. (2017). Targeting Integrin α4β7 in Steroid-Refractory Intestinal Graft-versus-Host Disease. Biology of Blood & Marrow Transplantation, 23(1), 172–175. https://doi.org/10.1016/j.bbmt.2016.10.009
Chicago
Fløisand, Yngvar, Knut E.A. Lundin, Vladimir Lazarevic, Jørn Dehli Kristiansen, Liv T.N. Osnes, Geir E. Tjønnfjord, Henrik Mikael Reims, and Tobias Gedde-Dahl. 2017. “Targeting Integrin Α4β7 in Steroid-Refractory Intestinal Graft-versus-Host Disease.” Biology of Blood & Marrow Transplantation 23 (1): 172–75. doi:10.1016/j.bbmt.2016.10.009.